Moderna Inc. is a biotechnology company at the forefront of messenger RNA (mRNA) therapeutics and vaccines. With a focus on developing innovative drugs, Moderna utilizes mRNA technology to stimulate protein or antibody production within patient cells. Their diverse pipeline encompasses prophylactic vaccines, therapeutic vaccines, intratumoral immuno-oncology, localized therapeutics, and liver intracellular treatments. Leveraging their mRNA therapeutics platform, Moderna pioneers the development and production of human proteins, antibodies, and novel proteins for disease prevention, treatment, and cure. They are actively involved in infectious disease, rare liver disease, immuno-oncology, and cardiovascular disease therapeutics.
$500M • 2017 • Series G
Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
Oshi Health is a digital health platform that provides personalized support and resources for people with digestive health conditions. Oshi Health raised $30M in 2023 with this deck.
Carrum Health is a value-based healthcare platform that ensures patients receive quality and less expensive care. Carrum Health raised $45M in 2023 with this deck.
98point6 is a digital care service that provides personalized consultation, diagnosis, and treatment to patients. 98point6 raised $30.7M in 2023 with this deck.
FOLX Health is the first digital healthcare service provider designed by and for the medical needs of the LGBTQIA+ community. Folx Health raised $30M in 2022 with this deck.
No spam. Up to 2 emails/mo – only the good stuff!